According to Newsweek. New Hampshire Pharmacies Could Soon Dispense Ivermectin Without Doctor Approval
Oh My!
Ivermectin
SOURCE: Mike Stewart
There’s a House bill in New Hampshire that if passes would allow Ivermectin to be issued by Pharmacists. An information sheet would also be issued with the drug. Under the law, pharmacists would be able to "dispense ivermectin under the delegated prescriptive authority of the physician or APRN (Advanced Practice Registered Nurses), specify a mechanism to document screening performed and the prescription in the patient's medical record, and include a plan for evaluating and treating adverse events," according to the bill.
Republican State Rep. Leah Cushman, a sponsor of the bill and registered nurse, told Newsweek that she wanted to make sure residents of the state "have options for treatment of COVID-19." She also said that the burden of the virus on hospitals needs to be curbed, "and right now there are no early treatments being offered by most doctors."
In regard to some of the pushback against the bill, Cushman said that the House committee was working on a bipartisan amendment to address some of the concerns. This includes requiring that patients who receive the drug are informed that its use for COVID-19 is "off-label" and setting guidelines for tracking any adverse effects, she said.
"I think we can work together to get it an Ought to Pass recommendation from the committee," Cushman said.
This writer is not for or against the use of Ivermectin or any other drug that’s shown to be tested and shown to be effective against COVID. Only drug that I see that’s most effective is fluvoxamine.
This from the NIH.
Findings: The study team screened 9803 potential participants for this trial. The trial was initiated on June 2, 2020, with the current protocol reporting randomisation to fluvoxamine from Jan 20 to Aug 5, 2021, when the trial arms were stopped for superiority. 741 patients were allocated to fluvoxamine and 756 to placebo. The average age of participants was 50 years (range 18-102 years); 58% were female. The proportion of patients observed in a COVID-19 emergency setting for more than 6 h or transferred to a teritary hospital due to COVID-19 was lower for the fluvoxamine group compared with placebo (79 [11%] of 741 vs 119 [16%] of 756); relative risk [RR] 0·68; 95% Bayesian credible interval [95% BCI]: 0·52-0·88), with a probability of superiority of 99·8% surpassing the prespecified superiority threshold of 97·6% (risk difference 5·0%). Of the composite primary outcome events, 87% were hospitalisations. Findings for the primary outcome were similar for the modified intention-to-treat analysis (RR 0·69, 95% BCI 0·53-0·90) and larger in the per-protocol analysis (RR 0·34, 95% BCI, 0·21-0·54). There were 17 deaths in the fluvoxamine group and 25 deaths in the placebo group in the primary intention-to-treat analysis (odds ratio [OR] 0·68, 95% CI: 0·36-1·27). There was one death in the fluvoxamine group and 12 in the placebo group for the per-protocol population (OR 0·09; 95% CI 0·01-0·47). We found no significant differences in number of treatment emergent adverse events among patients in the fluvoxamine and placebo groups.
Interpretation: Treatment with fluvoxamine (100 mg twice daily for 10 days) among high-risk outpatients with early diagnosed COVID-19 reduced the need for hospitalisation defined as retention in a COVID-19 emergency setting or transfer to a tertiary hospital.
I Purposely used a test from a country outside of the USA cause I knew a person masquerading as a medical expert would jump on it. ( Rumor has it that the proper authorities were notified. ). Fluvoxamine is being tested world wide as a drug to take when COVID is in it's early stages. Guess who else is on the band wagon of it's testing? The NIH. There are 9 tests that the NIH is following at this time. So far all the clinical studies show that this $4.00 pill is working. "A 10-day course of fluvoxamine costs approximately $4.
All or part of 22 countries around the globe have approved the use of ivermectin in the treatment of COVID-19, based on multiple studies.
https://c19adoption.com
https://c19ivermectin.com
https://www.theepochtimes.com/mkt_app/ivermectin-safe-and-effective-for-treating-omicron-japanese-company_4246848.html?v=ul